We count on Orchard Therapeutics plc ORTX to beat expectations when it studies fourth-quarter and full-year 2020 outcomes. The corporate ought to present updates on the launch actions of Libmeldy (OTL-200) in Europe.
www.nasdaq.com
What's in Retailer for Orchard Therapeutics (ORTX) This fall Earnings?
